One of the rare diseases of the adults is in the acute lymphoblastic leukemia. In the case of the children, the control of this disease is much more simple and easier than that of the adults. In the recent techniques and methodologies, the application s of the pediatric protocols has better the conditions of eth survival of the young adults’ patients. Methods: To accomplish the research, the epidemiology and the end One of the rare diseases of the adults is in the acute lymphoblastic leukemia. In the case of the children, the control of this disease is much more simple and easier than that of the adults. In the recent techniques and methodologies, the application s of the pediatric protocols has better the conditions of eth survival...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed d...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood...
BACKGROUND: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood...
Acute lymphoblastic leukemia (ALL), a common child malignancy, also constitutes a minor fraction of ...
Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are in...
Acute lymphoblastic leukemia (ALL) in adults is a rare malignancy. It represents 1-2% of all cancers...
Objectives: As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results ...
Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results o...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
This nationwide population-based study assessed trends in treatment, trial participation and surviva...
Acute leukemia (AL) is a rare, potentially curable, aggressive neoplasm of hematopoietic origin. AL ...
It is a new and exciting time for acute lymphoblastic leukemia (ALL). While nearly 50 years ago, onl...
Background: Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed d...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Background: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood...
BACKGROUND: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood...
Acute lymphoblastic leukemia (ALL), a common child malignancy, also constitutes a minor fraction of ...
Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are in...
Acute lymphoblastic leukemia (ALL) in adults is a rare malignancy. It represents 1-2% of all cancers...
Objectives: As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results ...
Objectives As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results o...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
This nationwide population-based study assessed trends in treatment, trial participation and surviva...
Acute leukemia (AL) is a rare, potentially curable, aggressive neoplasm of hematopoietic origin. AL ...
It is a new and exciting time for acute lymphoblastic leukemia (ALL). While nearly 50 years ago, onl...
Background: Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (...
Background: The objective was to compare 5-year overall survival (OS) between adolescent and young a...
Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed d...
To access publisher's full text version of this article, please click on the hyperlink in Additional...